Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 4.4% – Here’s What Happened

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s share price dropped 4.4% during trading on Thursday . The stock traded as low as $17.38 and last traded at $17.50. Approximately 11,323 shares were traded during trading, a decline of 64% from the average daily volume of 31,666 shares. The stock had previously closed at $18.30.

Analysts Set New Price Targets

A number of brokerages have weighed in on TLX. UBS Group upped their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, January 27th. William Blair reaffirmed an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The firm’s 50 day moving average is $17.88.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.